Cargando…
Identification of a robust gene signature that predicts breast cancer outcome in independent data sets
BACKGROUND: Breast cancer is a heterogeneous disease, presenting with a wide range of histologic, clinical, and genetic features. Microarray technology has shown promise in predicting outcome in these patients. METHODS: We profiled 162 breast tumors using expression microarrays to stratify tumors ba...
Autores principales: | Korkola, James E, Blaveri, Ekaterina, DeVries, Sandy, Moore, Dan H, Hwang, E Shelley, Chen, Yunn-Yi, Estep, Anne LH, Chew, Karen L, Jensen, Ronald H, Waldman, Frederic M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855059/ https://www.ncbi.nlm.nih.gov/pubmed/17428335 http://dx.doi.org/10.1186/1471-2407-7-61 |
Ejemplares similares
-
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
por: Chen, Yunn-Yi, et al.
Publicado: (2009) -
Phenotypic Robustness and the Assortativity Signature of Human Transcription Factor Networks
por: Pechenick, Dov A., et al.
Publicado: (2014) -
Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
por: Bing, Zhitong, et al.
Publicado: (2019) -
Possible DCC signature in $\gamma$-hadron families seen through robust observables
por: Augusto, C R A, et al.
Publicado: (1998) -
1216. Benchmarking Published Gene Signatures for Robust Infection Classification
por: Bodkin, Nicholas, et al.
Publicado: (2020)